Your browser doesn't support javascript.
loading
High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients.
Prediletto, Irene; Farag, Sarah A; Bacher, Ulrike; Jeker, Barbara; Mansouri Taleghani, Behrouz; Brégy, Rachel; Zander, Thilo; Betticher, Daniel; Egger, Thomas; Novak, Urban; Pabst, Thomas.
Afiliação
  • Prediletto I; Department of Medical Oncology, University Hospital and University of Bern, Bern, Switzerland.
  • Farag SA; Department of Medical Oncology, University Hospital and University of Bern, Bern, Switzerland.
  • Bacher U; Department of Hematology and Central Hematology Laboratory, University Hospital and University of Bern, Bern, Switzerland.
  • Jeker B; Department of Medical Oncology, University Hospital and University of Bern, Bern, Switzerland.
  • Mansouri Taleghani B; Department of Hematology and Central Hematology Laboratory, University Hospital and University of Bern, Bern, Switzerland.
  • Brégy R; Department of Pharmacy, Inselspital, University Hospital and University of Bern, Bern, Switzerland.
  • Zander T; Department of Oncology, Kantonsspital, Lucerne, Switzerland.
  • Betticher D; Department of Oncology, Kantonsspital, Fribourg, Switzerland.
  • Egger T; Department of Oncology, Bürgerspital, Solothurn, Switzerland.
  • Novak U; Department of Medical Oncology, University Hospital and University of Bern, Bern, Switzerland.
  • Pabst T; Department of Medical Oncology, University Hospital and University of Bern, Bern, Switzerland. thomas.pabst@insel.ch.
Bone Marrow Transplant ; 54(12): 1923-1925, 2019 12.
Article em En | MEDLINE | ID: mdl-30890768
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Alquilantes / Cloridrato de Bendamustina / Rim / Linfoma / Mieloma Múltiplo Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Alquilantes / Cloridrato de Bendamustina / Rim / Linfoma / Mieloma Múltiplo Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suíça